Coherent Inc (COHR)vsZepp Health Corp (ZEPP)
COHR
Coherent Inc
$304.93
+0.32%
TECHNOLOGY · Cap: $59.94B
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Coherent Inc generates 2331% more annual revenue ($6.29B vs $258.90M). COHR leads profitability with a 4.7% profit margin vs -15.5%. COHR earns a higher WallStSmart Score of 52/100 (C-).
COHR
Buy52
out of 100
Grade: C-
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-26.6%
Fair Value
$176.68
Current Price
$304.93
$128.25 premium
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 73.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
17.5% revenue growth
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Distress zone — elevated risk
ROE of 3.2% — below average capital efficiency
4.7% margin — thin
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : COHR
The strongest argument for COHR centers on EPS Growth, Market Cap, PEG Ratio. Revenue growth of 17.5% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : COHR
The primary concerns for COHR are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 313.4x leaves little room for execution misses. Thin 4.7% margins leave little buffer for downturns.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
COHR profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
COHR carries more volatility with a beta of 1.91 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
COHR scores higher overall (52/100 vs 41/100) and 17.5% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Coherent Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?